Patents by Inventor Matthew Idso

Matthew Idso has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SARS-CoV-2 epitope-targeted peptide immunostimulants
    Patent number: 12209142
    Abstract: Disclosed are compounds, compositions, and methods relating to epitope-targeted immunostimulants (EPIs), which comprise a synthetic peptide ligand and an antibody-recruiting moiety. The peptide ligand binds an epitope on a target and the antibody-recruiting moiety recruits antibodies to the target when the EPI is bound to the epitope on the target. Also disclosed are compositions comprising any of the disclosed EPIs. Also disclosed are methods of stimulating an immune reaction to a microorganism or other pathogen in a subject where an EPI is administered to the subject. Also disclosed are methods of identifying the peptide ligand by using multi-omic analysis.
    Type: Grant
    Filed: June 1, 2021
    Date of Patent: January 28, 2025
    Assignees: Institute for Systems Biology, The United States of America as Represented by The Secretary of the Army
    Inventors: James R. Heath, Matthew Idso, Alexander J. Winton, Matthew B. Coppock, Sanchao Liu
  • SARS-CoV-2 EPITOPE-TARGETED PEPTIDE IMMUNOSTIMULANTS
    Publication number: 20210380640
    Abstract: Disclosed are compounds, compositions, and methods relating to epitope-targeted immunostimulants (EPIs), which comprise a synthetic peptide ligand and an antibody-recruiting moiety. The peptide ligand binds an epitope on a target and the antibody-recruiting moiety recruits antibodies to the target when the EPI is bound to the epitope on the target. Also disclosed are compositions comprising any of the disclosed EPIs. Also disclosed are methods of stimulating an immune reaction to a microorganism or other pathogen in a subject where an EPI is administered to the subject. Also disclosed are methods of identifying the peptide ligand by using multi-omic analysis.
    Type: Application
    Filed: June 1, 2021
    Publication date: December 9, 2021
    Inventors: James R. Heath, Matthew Idso